In 2023, the global bee venom extract market is estimated at US$ 378.0 million. The market is likely to reach nearly US$ 618.6 million by 2033, with a growing CAGR of 5.0% from 2023 to 2033.bee venom extract market is estimated at US$ 378.0 million. The market is likely to reach nearly US$ 618.6 million by 2033, with a growing CAGR of 5.0% from 2023 to 2033.
The demand for bee venom in modern-day medicine is growing steadily as it has anti-inflammatory properties. It claims it can treat rheumatoid arthritis, psoriasis, acne, nerve pain, multiple sclerosis, and scarring from skin cancer. American Apitherapy Association says that Apitherapy or bee therapy is a therapeutic use of products made from honeybees such as bees and bee venoms. Ailments that usually do not respond to traditional Western medicine are treated using bee venom.The demand for bee venom in modern-day medicine is growing steadily as it has anti-inflammatory properties and claims that it can treat rheumatoid arthritis, psoriasis, acne, nerve pain, multiple sclerosis, and scarring from skin cancer. American Apitherapy Association says that Apitherapy or bee therapy is a therapeutic use of products made from honeybees such as bees and bee venoms. Ailments that usually do not respond to traditional Western medicine are treated using bee venom treatment.
Driving Forces in the Bee Venom Extract Industry
Challenges for Companies and Manufacturers in the Bee Venom Extract Industry
Investment Opportunities in the Bee Venom Extract Industry
Latest Trends in the Bee Venom Extract Industry
Report Attribute | Details |
---|---|
Bee Venom Extract Market Value (2023) | US$ 378.0 million |
Bee Venom Extract Market Anticipated Value (2033) | US$ 618.6 million |
Bee Venom Extract Projected Growth Rate (2023 to 2033) | 5.0% |
Nearly 10000 bee stings make as little as one gram of bee venom. Therefore, bee venom is almost seven times more valuable than gold. The bee venom extracts market growth is credited to increasing demand for enhancing healthcare infrastructure in several countries like India, the USA, and other European countries. One of the key market-driving factors of bee venom extract is the increasing prevalence of individuals suffering from hormonal disorders. bee stings make as little as one gram of bee venom, therefore bee venom is almost seven times more valuable than gold. The bee venom extract market growth is credited to increasing demand for enhancing healthcare infrastructure in several countries like India, the USA, and several other European countries. One of the key market-driving factors of bee venom extract is the increasing prevalence of individuals suffering from hormonal disorders.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Bee venom is widely used in the pharmaceutical industry, and this is one of the primary factors for the growth of this market. Bee venom has been proven to benefit when used therapeutically. For instance, bee venom extracts have been extensively used in Europe for a long time for treating rheumatic infections. Bee venom, as well as live bees, are used for the treatment.
Apitherapy is a substitutive therapy that depends on the use of honeybee products, especially bee venom extracts, for treating several diseases. The demand for bee venom is steadily surging considering its several beneficial properties, as they contain various active molecules such as enzymes and peptides that can potentially treat inflammation and central nervous system diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis.
The bee venom extract market is showing promising growth globally, as it has benefitted the cancer segment of the medical industry. Bee venom is said to benefit various cancer types along with its anti-viral activity. It is even likely to challenge the immunodeficiency virus (HIV).
There has been an increasing adoption of bee venom extracts in the cosmetic and skin care industry. Some cosmetic applications of bee venom are facial wrinkles, psoriasis, atopic dermatitis, wound healing, vitiligo, acne vulgaris, androgenetic alopecia, etc.
Researchers say that bee venom and other bee-derived ingredients could be promising agents as skin care actives to aim for nourishment, smoothness, and brightness. However, commercialization will need thorough attention given allergenicity concerns. Bee venom as a cosmetic ingredient is swiftly increasing and gaining popularity owing to its potential to fool the skin into believing it has been stung. This increases collagen production and blood circulation.Researchers say that bee venom and other bee-derived ingredients could be promising agents as skin care actives to aim for nourishment, smoothness, and brightness, though commercialization will need thorough attention given allergenicity concerns. Bee venom as a cosmetic ingredient is swiftly increasing and gaining popularity owing to its potential to fool the skin into believing that it has been stung. This increases collagen production and blood circulation.
The North American bee venom extract market is accountable for 32.1% market share in the global market. This region's market growth is anticipated to be sluggish but steady compared to other regions. The factors such as growing consumer awareness about the health benefits of beef byproducts, increasing need for nutritious food products, and growing application of bee venom in the healthcare industry are propelling the growth of the bee venom extracts market in North America. the health benefits of beef byproducts, increasing need for nutritious food products, and growing application of bee venom in the healthcare industry are propelling the growth of the bee venom extracts market in North America.
Some factor resisting the growth of bee venom is not much availability of beehives in the USA. Owing to the absence of honeybees, bee venom is in shortage, and therefore no applicable clinical testing or analysis can be done.Some factor resisting the growth of bee venom is not much availability of beehives in the USA, owing to the absence of honeybees, bee venom is in shortage, and therefore no applicable clinical testing or analysis can be done.
The Europe region is attributable to 27.9% market share in the global bee venom market. This region's market is dominating and is anticipated to remain in a steady position during the forecast period. The growth is attributed to significant use for treating rheumatic diseases, and bee venom extracts and love honeybees both are used for medical treatments in Europe. Europe is widely incorporating apitherapy owing to the accessibility of wide-ranging products. European countries have broad applications of bee venom. These countries have apitherapy which is unique owing to the availability of a wide range of products.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
A Dunedin, New Zealand-based skincare start-up Bee, you are making a buzz in the rising competitive world of natural cosmetic skin products. The primary foundation of Bee Yu's skincare range is active manuka honey and bee venom, along with botanicals such as harakeke, kiwifruit, and total extract sourced from New Zealand. A nutraceutical company, Alaron in Nelson, is manufacturing, and the brand is being welcomed locally, and in the United Kingdom, most of the sales are derived online
Some of the key players in the bee venom extract market are Bee Whisper, ApiHealth NZ Ltd, Fernz, Abeeco Pure, Citeq Biologics, and Others. A few of the strategies adopted by the key players in the market are partnership and collaboration with other operators, expansion into the untapped market, and joint ventures with organizations in emerging countries to gain a strong foothold in the market.
ApiHealth Launched two new bee venom products in the market - Ultra Lifting Firming Mask and Platinum Wrinkle Solution Mask were successfully registered onto the European Cosmetics Products Notification Portal (CPNP). ApiHealth also has a significant bee venom product, i.e., bee venom cream ApiVENZ™ Relief for individuals suffering from muscle and joint pain. Individuals who have strained tendons or sports injuries greatly benefit from this.
Recent Developments
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 5.0% from 2023 to 2033 |
Base Year for Estimation | 2022 |
Historical Data | 2018 to 2022 |
Forecast Period | 2023 to 2033 |
Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
Customization | Available Upon Request |
The net extraction of bee venom is forecasted to surge at 5% CAGR until 2033..
The net worth of all commercial bee venom extract available in 2023 is around US$ 378 million.
Sales of bee venom extracts in North America was around 32.1% of the global sales in 2022.
The European countries altogether contributed for almost 29% of the global market.
Bee venom extract is primarily used in niche cosmetics and skincare products..
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Tons) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Type, 2023 to 2033 5.3.1. Liquid 5.3.2. Powder 5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Application, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Pharmaceutical 6.3.2. Cosmetic & Personal care 6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Type 8.2.3. By Application 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Type 8.3.3. By Application 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Type 9.2.3. By Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Type 9.3.3. By Application 9.4. Key Takeaways 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. UK 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Type 10.2.3. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By Application 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Type 11.2.3. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By Application 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Type 12.2.3. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By Application 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Type 13.2.3. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By Application 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Type 14.2.3. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By Application 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Type 15.1.2.2. By Application 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Type 15.2.2.2. By Application 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Type 15.3.2.2. By Application 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Type 15.4.2.2. By Application 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Type 15.5.2.2. By Application 15.6. UK 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Type 15.6.2.2. By Application 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Type 15.7.2.2. By Application 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Type 15.8.2.2. By Application 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Type 15.9.2.2. By Application 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Type 15.10.2.2. By Application 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Type 15.11.2.2. By Application 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Type 15.12.2.2. By Application 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Type 15.13.2.2. By Application 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Type 15.14.2.2. By Application 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Type 15.15.2.2. By Application 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Type 15.16.2.2. By Application 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Type 15.17.2.2. By Application 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Type 15.18.2.2. By Application 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Type 15.19.2.2. By Application 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Type 15.20.2.2. By Application 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Type 15.21.2.2. By Application 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2022 15.22.2.1. By Type 15.22.2.2. By Application 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2022 15.23.2.1. By Type 15.23.2.2. By Application 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Type 16.3.3. By Application 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. ApiHealth NZ Ltd. 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Bee Health Limited 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Nelson Honey & Marketing (NZ) Ltd. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Comvita Limited 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Nature's Health Products NZ Ltd. 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. BeeVital GmbH 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Queen Bee Parfums 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. Bee Venom Lab 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. Nature's Aid 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Vitabeez 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Food and Beverage Insights
View Reports